McGlone Suttner Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580K Buy
4,593
+174
+4% +$22.9K 0.07% 119
2026
Q1
$616K Sell
4,419
-1,378
-24% -$193K 0.08% 108
2025
Q4
$711K Buy
5,797
+1,116
+24% +$136K 0.1% 94
2025
Q3
$520K Buy
4,681
+251
+6% +$28.5K 0.07% 114
2025
Q2
$491K Buy
4,430
+368
+9% +$39.2K 0.07% 118
2025
Q1
$455K Buy
4,062
+1,126
+38% +$116K 0.07% 124
2024
Q4
$271K Buy
2,936
+195
+7% +$17.6K 0.05% 146
2024
Q3
$230K Sell
2,741
-1,401
-34% -$107K 0.05% 154
2024
Q2
$336K Buy
+4,142
New +$276K 0.07% 112
2024
Q1
Sell
-4,142
Closed -$336K 424
2023
Q4
$336K Buy
4,142
+201
+5% +$15.6K 0.07% 112
2023
Q3
$295K Buy
3,941
+193
+5% +$14.8K 0.07% 107
2023
Q2
$289K Buy
3,748
+167
+5% +$13.3K 0.07% 114
2023
Q1
$297K Buy
3,581
+124
+4% +$10.3K 0.08% 106
2022
Q4
$297K Buy
+3,457
New +$274K 0.09% 96

Other funds holding GILD

McGlone Suttner Wealth Management's GILD Position: Q2 2026 in Review

McGlone Suttner Wealth Management increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $22.9K and bringing the position to 4,593 shares worth $580K. The position accounts for 0.07% of the portfolio, ranked #119.

McGlone Suttner Wealth Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $711K in Q4 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • McGlone Suttner Wealth Management held 4,593 shares of Gilead Sciences worth $580K as of Q2 2026.
  • McGlone Suttner Wealth Management bought 174 Gilead Sciences shares in Q2 2026, an estimated $22.9K.
  • Gilead Sciences made up 0.07% of McGlone Suttner Wealth Management's portfolio in Q2 2026, its #119 holding.
  • McGlone Suttner Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • McGlone Suttner Wealth Management's Gilead Sciences position peaked at $711K in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on McGlone Suttner Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.